GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 56 Sr No Directorship in listed entities Category of Directorship Expertise in Specific Functional Areas 1 Bajaj Auto Limited Independent Director Human Resource, Administration, Security and Intelligence matters, Anti- Corruption & Vigilance 2 Bajaj Holdings & Investment Limited Independent Director 3 Bajaj Finance Limited Independent Director 4 Bajaj Finserv Limited Independent Director 5 Finolex Industries Independent Director M r. Pradeep Bhide – Independent Director (DIN: 03304262) Mr. Bhide, Science and Law graduate from Delhi University, has done his Master’s in Business Administration from IGNOU. He is enrolled as an Advocate with Delhi Bar Council. Mr. Bhide joined the Indian Administrative Service in 1973 and has served for 37 years. He held a series of increasingly senior positions at the State and Central levels. He worked as Secretary for Department of Finance and then Department of Energy of Andhra Pradesh. He was a Deputy Secretary / Director in the Department of Economic Affairs, Ministry of Finance and served as Advisor to India’s Executive Director to the International Board for Reconstruction and Development, Washington. Mr. Bhide then served as Additional Secretary / Special Secretary in the Ministry of Home Affairs of the Government before being appointed as Secretary in the Department of Disinvestment with the Ministry of Finance. Mr. Bhide retired as Secretary, Department of Revenue, Ministry of Finance in January 2010, a position which he held from June 2007. He is a member of Audit Committee, Risk Management Committee and Stakeholders Relationship Committee. Sr No Directorship in listed entities Category of Directorship Expertise in Specific Functional Areas 1 Borosil Renewables Limited Independent Director Finance, Administration & Taxation 2 L&T Finance Holdings Limited Independent Director 3 Nocil Limited Independent Director M r. Subesh Williams – Non- Executive Director (DIN: 07786724) Subesh Williams, 59, is a Chartered Accountant and Senior Vice President, Global Corporate Development at GSK plc, a role he was appointed to in September 2013. In his current role, Subesh is responsible for M&A and Business Development across GSK’s commercial businesses and has been involved in executing numerous transactions, including the creation of ViiV Healthcare (a HIV JV with Pfizer and Shionogi), the combination of the Consumer Healthcare businesses of GSK and Pfizer in a joint venture and more recently in leading the demerger of Haleon, the Consumer Healthcare business from GSK. In 2016, Subesh was appointed to the Board of Galvani Bioelectronics, a joint venture between GSK and Verily (a subsidiary of Alphabet). From 2009- 2013, Subesh was Chief Financial Officer of ViiV Healthcare, with responsibility for Finance, Business Development, IT and Supply and prior to that has had roles of increasing responsibility in Finance and Corporate Development. Prior to joining GSK he was a Manager at PwC. He was appointed with effect from 7 April 2017. He has expertise in the fields of Finance, Business development and Mergers & Acquisitions. He does not hold any shares in the Company and is also not related to any Directors of the Company. M r. Sridhar Venkatesh – Managing Director (DIN: 07263117) Mr. Sridhar is a senior business leader with more than 24 years of diverse experience in pharmaceuticals & healthcare and has a strong track record of success in multiple roles within GSK. Sridhar joined GSK in 2011 as Head of Commercial, Established Products, Branded Generics, and moved as General Manager, Singapore before taking up the role of Commercial Head, India from 2014 to 2016. He was then promoted as VP of Central America & Caribbean before taking the role as VP, Emerging Markets East, with direct management of six markets (Philippines, Vietnam, Thailand, Malaysia, Indonesia, and Sri Lanka). Sridhar began his career with Eli Lilly and then moved to Pfizer and held increasingly senior roles including the role of Senior Director, Business Development (Asia) for Pfizer, before joining GSK. Sridhar is a Registered Pharmacist, with a Master’s in Pharmacy (Pharmaceutical Marketing). He is member of Stakeholders Relationship Committee and Corporate Social Responsibility Committee. He is Director in Biddle Sawyer Limited. Annexure ‘C’ Report on Corporate Governance